Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tight junction protein 1 (ZO-1) is a vital peripheral membrane scaffolding protein and a member of the membrane-associated guanylate kinase (MAGUK) family. It acts as a primary molecular bridge at the cytoplasmic surface of intercellular tight junctions, linking transmembrane proteins like claudins and occludin to the perijunctional actin cytoskeleton. This structural role is essential for maintaining the "gate" and "fence" functions of epithelial and endothelial barriers, which regulate paracellular permeability and preserve cell polarity. Beyond its scaffolding function, ZO-1 participates in critical signal transduction pathways, including Hippo signaling, to regulate cell proliferation, differentiation, and tissue morphogenesis. In clinical contexts, the downregulation or redistribution of ZO-1 is a hallmark of barrier dysfunction in diseases such as celiac disease and inflammatory bowel disease, while its overexpression is often linked to epithelial-mesenchymal transition and metastasis in several cancers. Therapeutic efforts involve tight junction modulators like larazotide acetate, which acts as a zonulin antagonist to stabilize the ZO-1 complex and restore intestinal barrier integrity.
Modulation of tight junction assembly and stabilization of the ZO-1 scaffolding complex at the cell membrane to restore or regulate epithelial barrier integrity.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tight junction protein 1 (ZO-1) (ZO-1).